Elder Granger
Independent DirectorMajor General Elder Granger, M.D., MG FACP, CPE, FACPE, FACHE, CMQ, USA (Retired) is Member of Medical Advisory Board of RAIsonance, Inc. Major General Granger serves as the President and Chief Executive Officer of the 5Ps, LLC, SDVOSB since August 6, 2009, where he serves as an Advisor, Director and Consultant to a variety of healthcare technology and service companies. He serves as Member of the Advisory Board of First Tellurium Corp. since November 2025 and as Member of the Scientific Advisory Board of Floreo, Inc. since June 2025. He has been an Independent Director at Better Therapeutics, Inc. since November 2021 and serves as Member of the Advisory Board of Nanocan Therapeutics Corporation since November 2021. He has been a Member of the Advisory Board of Alderman & Company Capital, LLC since August 2020 and serves as Member of the Advisory Board at Alderman & Company since August 2020. He has been a Director of DLH Holdings Corp. since November 13, 2014. He is Advisor at 1104Health, Inc., serves as Member of the Advisory Board at Caregility Corporation and serves as a Member of the Health Advisory Board at Client Network Services, Inc. He serves as Director at kaleo, Inc., has been Director at Decisio Health, Inc. and serves as Member of the Health Care Advisory Board of Acentra Health. He has been Member of the Advisory Board at LynkCare LLC and serves as Strategic Advisor at Arsenal Venture Partners, Inc., where he advises AVP on their healthcare investment efforts, as well as works with AVP's respective portfolio companies. He serves as Interim Chief Medical Officer at BERG, LLC and is Member of the Board of Advisors at Future Life, Inc. He serves as a Director of Acentia, LLC, Berg Healthcare, Defense Logistics Health and DocBox. He serves as a Member of the Medical Advisory Board at Microdermis Corporation, as a Member of the Advisory Council at Capsule Technologies, Inc. and as a Member of the Advisory Board of Unison Marketplace, Inc. He serves on the Board of Trustees of Rosalind Franklin University of Medicine and Science, on the Board of Visitors of the University of Arkansas School of Medicine and as Member of the Advisory Board at Boyd Street Ventures. He had been an Independent Director of The Cigna Group since December 2018 until December 31, 2025. He had been Member of the Military Advisory Board at Sparta Software Corporation until April 2023. He served as an Independent Director at Cerner Corporation from November 16, 2020 to June 8, 2022. He served as an Independent Director of Express Scripts Holding Company from 2015 to December 20, 2018. He retired from the U.S. Army in July 2009. He served as the Deputy Director and Program Executive Officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs), from December 2005 to June 2009. He served as the Chief Medical Officer and as Chief Medical Informatics Officer of Capital Technology Information Services, Inc. since September 21, 2015. He served as a Director of Recondo Technology, Inc. since June 2012. He served as a Member of the Strategic Advisory Board at DLH Holdings Corp. since July 2011. He served as a Member of the Advisory Board at Binary Group, Inc. and as a Member of the Board of Advisors at DefenseWeb Technologies, Inc. Within the U.S. Army, he served as the Principal Advisor to the Assistant Secretary of Defense (Health Affairs) on DoD health plan policy and performance. Prior to joining TRICARE Management Activity, he led the multi-national battlefield health system while serving as Commander, Task Force 44th Medical Command and Command Surgeon for the Multinational Corps Iraq. His previous assignments included Commander of 44th Medical Command, XVIII Airborne Corps Command Surgeon and Director of Health Services for Fort Bragg; Commander of US Army Europe Regional Medical Command, US Army Europe and Seventh Army Command Surgeon and TRICARE Lead Agent Europe; Acting Assistant Surgeon General for Force Projection for Office of the Surgeon General, Department of the Army; Commander of Landstuhl Regional Medical Center; Commander of Ireland Army Community Hospital; Division Surgeon of 4th Infantry Division; Deputy Commander for Clinical Services, Raymond W. Bliss Army Community Hospital; Chief of Department of Medicine and Hematology Service, 2nd General Hospital; and Staff Hematologist/Oncologist, Fitzsimons Army Medical Center. He began his career with the Army Medical Department in 1971 as a Combat Medic in the U.S. Army National Guard. He earned a Bachelor of Science degree; Doctor of Science in Zoology/Animal Biology from Arkansas State University between 1973 and 1976 and a Doctor of Medicine from the University of Arkansas for Medical Sciences, College of Medicine between 1976 and 1980. He completed a residency in Internal Medicine in 1983 and a fellowship in Hematology-Oncology in 1986 at Fitzsimons Army Medical Center. His Military education includes the Army War College, Army Command and General Staff College, Army Medical Department Officer Advanced and Basic Courses, Military Health System and Army CAPSTONE Courses and Combat Casualty Care Course.
Positions
- Company NameBetter Therapeutics, Inc.Stock CodeBTTXPositionIndependent DirectorColleagues
- DPDavid P. PerryCo-Founder & Executive Chairman
- FLFrank L. KarbeInterim CFO
- MAMark A. BermanChief Medical Officer
- KWKristin WynholdsChief Product Officer
- ACAndres CamachoSenior VP of Technology & Head of Engineering
- AJAndrew J. ArmaninoIndependent Director
- GMGeoffrey M. ParkerIndependent Director
- RHRichard H. CarmonaIndependent Director
